Clinical Trial Update: Study to Evaluate ARD-101 in Adults Receiving Bariatric Surgery [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating ARD-101 in adults undergoing bariatric surgery has completed, and the results were posted on 2024-11-14.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• ARD-101

Snippet

Sponsor: Aardvark Therapeutics, Inc. | Conditions: Bariatric Surgery, Obesity | Phase 2 | Status: COMPLETED | Results posted: 2024-11-14